fig2

Figure 2. ImmuneScore as a predictor of early disease progression in patients receiving ICI therapy combined with chemotherapy. (A) PD-L1 TPS could not effectively predict early tumor progression; (B) ROC curve and corresponding AUC for PD-L1 TPS in predicting early disease progression; (C) ImmuneScore could predict early tumor progression; (D) ROC curve and corresponding AUC for ImmuneScore in predicting early disease progression. ICI: Immune checkpoint inhibitor; PD-L1 TPS: programmed cell death 1 ligand 1 tumor proportion score; ROC: receiver operating characteristic curve; AUC: area under the ROC curve; PD: progressive disease; PR: partial response; SD: stable disease.